Gray Zone Lymphoma: A Retrospective Multicenter Analysis of Clinical Characteristics, Treatment, Outcomes and Prognosis


Gray Zone Lymphoma: A Retrospective Multicenter Analysis of Clinical Characteristics, Treatment, Outcomes and Prognosis
Slides from a presentation at ASH 2013 and transcribed comments from a recent interview with Christopher Flowers, MD, MS (2/24/14)
Evens AM et al. Gray zone lymphoma (GZL) with features intermediate between classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL): A large retrospective multicenter analysis of clinical characteristics, treatment, outcomes and prognosis in the current era. Proc ASH 2013;Abstract 847.

Dr Flowers is Associate Professor of Hematology and Medical Oncology at Emory School of Medicine Winship Cancer Institute in Atlanta, Georgia.